Delving into the Latest Updates on Kaixing Life Technology (Shanghai) Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Immune System Diseases

Endocrinology and Metabolic Disease

Monoclonal antibody

Autologous CAR-T

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	3
Immune System Diseases	2
Endocrinology and Metabolic Disease	1
Hemic and Lymphatic Diseases	1
Infectious Diseases	1

Top 5 Drug Type	Count

Monoclonal antibody	2
Autologous CAR-T	1

Top 5 Target	Count

GPRC5D(G-protein coupled receptor family C group 5member D)	1
CLDN18.2(Claudin 18.2)	1
BCMA(B-cell maturation protein)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

Phase 1 Clinical

Approved

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Zevorcabtagene Autoleucel ( BCMA )	Multiple Myeloma More	Approved
AB-011 ( CLDN18.2 )	CLDN18.2 Positive Advanced Malignant Solid Neoplasm More	Phase 1
WO2023143537 ( GPRC5D )	Infectious Diseases More	Discovery